A New Hope for Heart Health!
Hey everyone! Let’s talk about something that affects millions of people worldwide: cardiovascular disease (CVD). High cholesterol is a major culprit, but what if we could just “turn off” the gene responsible for it? Well, that’s exactly what scientists are trying to do, and it’s about to be tested in humans for the first time!
Enter Scribe Therapeutics and their groundbreaking new therapy, STX-1150. This isn’t your typical daily pill. It’s an “epigenetic silencing therapy,” which sounds like something out of a sci-fi movie, but it’s very real. Instead of permanently cutting or altering your DNA like some gene-editing tools, this therapy works by simply telling a specific gene to quiet down.
The target here is a gene called PCSK9, which plays a big role in how our bodies handle LDL cholesterol (the “bad” kind). By using a specialized CRISPR-based tool, STX-1150 essentially puts a “do not disturb” sign on the PCSK9 gene in the liver. The result? A significant and durable drop in bad cholesterol levels!
What’s really exciting is that this could potentially be a one-time treatment. Imagine not having to worry about daily medications to keep your cholesterol in check! Preclinical studies in non-human primates have shown incredible promise, with efficient and long-lasting reductions in both PCSK9 and LDL cholesterol after just a single dose.
Now, the big news: Scribe Therapeutics is gearing up to start their first-in-human clinical trials for STX-1150 in mid-2026. This is a massive milestone! If successful, this epigenetic editor could revolutionize how we treat hypercholesterolemia and prevent cardiovascular disease. It’s a huge leap forward in precision medicine, offering a safer, non-permanent way to control our genes for better health. Keep your fingers crossed for these upcoming trials!
This topic is featured in Great News podcast episode 39.
The Great News Podcast is your source for positive news, inspiring stories, and good news from around the world. We skip the doom and gloom of mainstream media to focus on scientific breakthroughs, environmental wins, and the inspiring news that proves the world is getting better. Join Andrew McGivern for a dose of optimism and uplifting stories that will change your perspective on human progress.
It is easy to find the
Keep looking for the good in the world, because it is not only there – its everywhere.
The Great News podcast is brought to you by the Daily Quote.
Today, a discovery that could turn our oceans into a source of clean, green fuel. That's our lead story today.
Plus, we’ll look at a ”molecular staple” for hard-to-treat cancers, a way to silence cholesterol without permanently altering your DNA, and a wireless system that’s twice as efficient as Wi-Fi.
Turning Sunlight and Seawater into Hydrogen
How Stapled Peptides Could Change Cancer Treatment
How Laser Tech Is Rewriting the Rules of WirelessAnd don’t forget to stick around for the speed round where we’ll celebrate a historic victory against an ancient disease.Chile Eliminates Leprosy
Revolutionizing Brain Research and Treatment!
How CAR T Therapy Is Learning to Fight Cancer Smarter
If you like the Great News Podcast, you will love the Great News Letter. Because the Great News Podcast is Great but the Great News Letter is Greater!
The Great News Letter is an email newsletter that you can subscribe to for FREE and get all the good news delivered to your email inbox.
For this episode we got some feedback from Brian de V. You can leave feedback for the show too by going to greatnewspodcast.com/feedback.
Or if you listen in Spotify – leave a comment right there as you listen.
Until next time… and there will be a next time.
Keep looking for the good in the world because no only is it there, its everywhere!
Source:
